$CDXS News

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Codexis Enters Agreement With An Unnamed siRNA Drug Innovator To Explore Stereo-Defined Fragment Synthesis Using Its ECO Synthesis Manufacturing Platform

Codexis to Participate in Cantor Global Healthcare Conference 2026

Codexis (CDXS) Q2 2026 Earnings Call Transcript

Piper Sandler Maintains Overweight on Codexis, Lowers Price Target to $8

Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?

Codexis Inc (CDXS) (Q2 2026) Earnings Call Highlights: Biocatalysis Growth and ECO Synthesis ...

Codexis, Inc. Q2 2026 Earnings Call Summary

Codexis Q2 Earnings Call Highlights

Codexis, Inc. (CDXS) Q2 2026 Earnings Call Transcript

Codexis Reports Second Quarter 2026 Financial Results

Codexis Affirms FY2026 Sales Guidance of $72.000M-$76.000M vs $74.099M Est

Codexis Q2 EPS $(0.13) Beats $(0.14) Estimate, Sales $14.915M Beat $14.348M Estimate

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

Codexis 13G Filing Shows Telemark Fund LP Reported A 7.3% Stake In The Co As Of July 24, 2026

Codexis to Report Second Quarter 2026 Financial Results on August 11

Codexis: ECO Synthesis And Runway Reset Warrant An Upgrade (Rating Upgrade)

Codexis Files Prospectus For Offering 16.667M Common Shares

Codexis Announces Pricing of Public Offering of Common Stock

Why Codexis Stock Is Falling After Hours Today